AAM
AR Asset Management Portfolio holdings
AUM
$546M
Turnover
5.65%
1-Year Est. Return
24.08%
This Fund
S&P 500
This Quarter
Est. Return
-3.32%
1 Year Est. Return
+24.08%
3 Year Est. Return
+64.88%
5 Year Est. Return
+92.85%
10 Year Est. Return
+260.28%
AUM
$357M
AUM Growth
-$16.1M
(-4.3%)
Cap. Flow
-$99.9K
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
40.71%
Holding
112
New
2
Increased
11
Reduced
19
Closed
1
Avg Time Held
7.6
years
Top 10 Avg Time Held
6.3
years
Top 20 Avg Time Held
5.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$881K |
| 2 |
Vivmark Residential
VMRK
|
+$549K |
| 3 |
On Holding
ONON
|
+$316K |
| 4 |
Target
TGT
|
+$169K |
| 5 |
Marker Therapeutics
MRKR
|
+$168K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.59M |
| 2 |
Baxter International
BAX
|
+$210K |
| 3 |
TotalEnergies
TTE
|
+$100K |
| 4 |
Chevron
CVX
|
+$80.8K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$78K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 21.05% |
| 2 | Technology | 18.18% |
| 3 | Healthcare | 13.16% |
| 4 | Financials | 13.05% |
| 5 | Energy | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $45.9M | 12.88% |
268,333
-300
| -0.1% | -$55K |
2013 Q2
41 quarters
|
|
|
2
Chevron
CVX
$436B
| $19.1M | 5.35% |
113,136
-500
| -0.4% | -$80.8K |
2013 Q2
41 quarters
|
|
3
Merck
MRK
$364B
| $13.9M | 3.89% |
134,570
| – | – |
2013 Q2
41 quarters
|
|
4
Procter & Gamble
PG
$364B
| $10.9M | 3.06% |
74,809
-300
| -0.4% | -$45.8K |
2013 Q2
41 quarters
|
|
5
Philip Morris
PM
$320B
| $10.4M | 2.91% |
112,206
-300
| -0.3% | -$28.9K |
2013 Q2
41 quarters
|
|
6
Coca-Cola
KO
$395B
| $9.64M | 2.7% |
172,130
+350
| +0.2% | +$21K |
2013 Q2
41 quarters
|
|
7
Berkshire Hathaway Class A
BRK.A
$1.13T
| $9.57M | 2.68% |
18
| – | – |
2013 Q2
41 quarters
|
|
8
JPMorgan Chase
JPM
$890B
| $9.46M | 2.65% |
65,231
| – | – |
2013 Q2
41 quarters
|
|
|
9
Alphabet (Google) Class C
GOOG
$4.2T
| $8.56M | 2.4% |
64,940
-600
| -0.9% | -$78K |
2016 Q2
29 quarters
|
|
10
Iron Mountain
IRM
$33B
| $7.76M | 2.18% |
130,600
-1,000
| -0.8% | -$61.1K |
2020 Q1
14 quarters
|
|
11
Microsoft
MSFT
$3.96T
| $7.67M | 2.15% |
24,279
| – | – |
2013 Q2
41 quarters
|
|
12
Nike
NKE
$52.4B
| $7.49M | 2.1% |
78,370
-200
| -0.3% | -$20.6K |
2013 Q2
41 quarters
|
|
13
Berkshire Hathaway Class B
BRK.B
$1.13T
| $7.19M | 2.02% |
20,518
| – | – |
2013 Q2
41 quarters
|
|
14
PepsiCo
PEP
$176B
| $7.15M | 2.01% |
42,209
+200
| +0.5% | +$36.3K |
2013 Q2
41 quarters
|
|
15
Diageo
DEO
$51.2B
| $6.73M | 1.89% |
45,090
+50
| +0.1% | +$8.37K |
2013 Q2
41 quarters
|
|
|
16
Target
TGT
$70.6B
| $6.44M | 1.81% |
58,245
+1,330
| +2% | +$169K |
2013 Q2
41 quarters
|
|
17
AbbVie
ABBV
$501B
| $6.44M | 1.81% |
43,200
-300
| -0.7% | -$44K |
2013 Q2
41 quarters
|
|
18
Home Depot
HD
$295B
| $5.91M | 1.66% |
19,550
| – | – |
2013 Q2
41 quarters
|
|
19
Zoetis
ZTS
$31.1B
| $5.86M | 1.64% |
33,661
-239
| -0.7% | -$43.4K |
2013 Q2
41 quarters
|
|
20
Tanger
SKT
$3.94B
| $5.36M | 1.5% |
237,050
-1,100
| -0.5% | -$25.6K |
2013 Q2
41 quarters
|
|
21
Loews
L
$22.3B
| $4.93M | 1.38% |
77,917
| – | – |
2013 Q2
41 quarters
|
|
|
22
Johnson & Johnson
JNJ
$612B
| $4.86M | 1.36% |
31,180
-9,635
| -24% | -$1.59M |
2013 Q2
41 quarters
|
|
23
Pfizer
PFE
$166B
| $4.7M | 1.32% |
141,665
+90
| +0.1% | +$3.18K |
2013 Q2
41 quarters
|
|
24
Walt Disney
DIS
$188B
| $4.52M | 1.27% |
55,755
+1,465
| +3% | +$125K |
2013 Q2
41 quarters
|
|
25
IBM
IBM
$215B
| $4.41M | 1.24% |
31,452
| – | – |
2013 Q2
41 quarters
|
|
Similar funds
QAM
LF
SCM
TGAM
HW
UFF
DBG
TI
AR Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, AR Asset Management held 112 positions worth $357M, down 4.3% from $373M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 2.7%. AR Asset Management opened 2 new positions and exited 1, leaving the 112-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
- AR Asset Management's largest Q3 2023 buy was Vivmark Residential: 8,500 shares worth $499K.
- AR Asset Management added most to UnitedHealth in Q3 2023, an estimated $881K increase.
- AR Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $1.59M.
- AR Asset Management fully exited Baxter International in Q3 2023, selling an estimated $210K.
- AR Asset Management's ten largest holdings make up 41% of its $357M portfolio in Q3 2023.
- AR Asset Management opened 2 new positions and closed 1 in Q3 2023.
- AR Asset Management's portfolio value fell 4.3% quarter-over-quarter to $357M.
Based on AR Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.